Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (235)	7/27/1998 3:27:00 PM
From: aknahow	Read Replies (2) \| Respond to of 4974

Being owned by BVF is a real plus but doing a private placement means nothing. Most biotechs do private placements and until one sees the details one only knows they probably got screwed but not how. Private placements are done in part because it is too costly to do a direct private placement. Once the public already owns a companies stock the private placement will impact them, meaning any harsh terms in the private placement will be costly to the public owners of the stock but probably not to the new private buyers who may have no interest in the company as an investment.